Table 1 Socio-demographic and clinical characteristics of the 166 Chinese TB patients with multiple episodes of treatment history
Geographic locations | ||||||
|---|---|---|---|---|---|---|
Variables | West | East | Central | North | South | Total |
n = 22 | n = 29 | n = 38 | n = 52 | n = 25 | n =166 | |
Female sex | 5 (22.7) | 6 (20.7) | 8 (21.1) | 11 (21.2) | 6 (24.0) | 36 (21.7) |
Age (mean ± SD) | 46 ± 13.8 | 47 ± 13.9 | 45 ± 17.8 | 46 ± 14.5 | 42 ± 11.8 | 45 ± 14.7 |
Episodes of previous treatment history | ||||||
=2 | 8 (36.4) | 12 (41.4) | 20 (52.6) | 26 (50.0) | 12 (48.0) | 78 (47.0) |
>2 | 14 (63.6) | 17 (58.6) | 18 (47.4) | 26 (50.0) | 13 (52.0) | 88 (53.0) |
Cavity | 9 (40.9) | 11 (37.9) | 13 (34.2) | 22 (42.3) | 14 (56.0) | 69 (41.6) |
Concurrent disease | 2 (9.1) | 2 (6.9) | 3 (7.9) | 4 (7.7) | 2 (8.0) | 13 (7.8) |
Drug resistant profile | ||||||
MDR only | 6 (27.3) | 7 (24.1) | 13 (34.2) | 27 (51.9) | 9 (36.0) | 62 (37.3) |
MDR-FQR | 3 (13.6) | 2 (6.9) | 5 (13.2) | 6 (11.5) | 3 (12.0) | 19 (11.4) |
MDR-INJR | 1 (4.5) | 3 (10.3) | 2 (5.3) | 4 (7.7) | 1 (4.0) | 11 (6.6) |
Other 1st DR | 6 (27.3) | 9 (31.0) | 9 (23.7) | 7 (13.5) | 9 (36.0) | 40 (24.1) |
Other 2nd DR | 3 (13.6) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 3 (1.8) |
1st-2nd DR | 2 (9.1) | 7 (24.1) | 8 (21.1) | 6 (11.5) | 2 (8.0) | 25 (15.1) |
XDR | 0 (0) | 1 (3.4) | 1 (2.6) | 2 (3.8) | 1 (4.0) | 5 (3.0) |